Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides

Kidney International

Volumn 67, Issue 2, 2005, Pages 631-637

  Williams, Tracy A ^b   Mulatero, Paolo ^a   Filigheddu, Fabiana ^b   Troffa, Chiara ^b   Milan, Alberto ^b   Argiolas, Giuseppe ^b   Parpaglia, Paolo Pinna ^b   Veglio, Franco ^b   Glorioso, Nicola ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

11betaHSD2; Cortisol metabolites; Genetic polymorphisms; Pharmacogenomic

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MICROSATELLITE DNA; THIAZIDE DIURETIC AGENT;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; DIURETIC THERAPY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; PHOTOMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 12344335537     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67119.x     Document Type: Article

References (29)

1. KROZOWSKI ZS, FUNDER JW: Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci U S A 80:6056-6060, 1983
2. ARRIZA JL, WEINBERGER C, CERELLI G, et al: Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 237:268-275, 1987
3. STEWART PM, MURRY BA, MASON JI: Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 79:480-484, 1994
4. WHITE PC, MUNE T, AGARWAL AK: 11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18:135-56, 1997
5. LI A, LI KX, MARUI S, et al: Apparent mineralocorticoid excess in a Brazilian kindred: Hypertension in the heterozygote state. J Hypertens 15:1397-1402, 1997
6. WILSON RC, DAVE-SHARMA S, WEI JQ, et al: A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A 95:10200-10205, 1998
7. SORO A, INGRAM MC, TONOLO G, et al. Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension. Hypertension 25:67-70, 1995
8. BRAND E, KATO N, CHATELAIN N, et al: Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension. J Hypertens 16:1627-1633, 1998
9. AGARWAL AK, GIACCHETTI G, LAVERY G, et al: CA-repeat polymorphism in intron 1 of HSD11B2: Effects on gene expression and salt sensitivity. Hypertension 36:187-194, 2000
10. LOVATI E, FERRARI P, DICK B, et al: Molecular basis of human salt sensitivity: The role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 84:3745-3749, 1999
11. CAPPELLO N, RENDINE S, GRIFFO R, et al: Genetic analysis of Sardinia: I. Data on 12 polymorphisms in 21 linguistic domains. Ann Hum Genet 60:125-141, 1996
12. PIAZZA A: Who are the Europeans? Science 260:9-11, 1993
13. GLORIOSO N, MANUNTA P, FILIGHEDDU F, et al: The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 34:649-654, 1999
14. LEE YS, LORENZO BJ, KOUfis T, REIDENBERG MM: Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase. Clin Pharmacol Ther 59:62-71, 1996
15. FERRARI P, SANSONNENS A, DICK B, FREY FJ: In vivo 11beta-HSD-2 activity: Variability, salt-sensitivity, and effect of licorice. Hypertension 38:1330-1336, 2001
16. PREIBISZ JJ, SEALEY JE, ACETO RM, LARAGH JH: Plasma renin activity measurements: An update. Cardiovasc Rev Rep 3:787-804, 1982
17. MULATERO P, SCHIAVONE D, FALLO F, et al: CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 35:694-698, 2000
18. MUNE T, ROGERSON FM, NIKKILA H, et al: Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 10:394-399, 1995
19. SMOLENICKA Z, BACH E, SCHAER A, et al: A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab 83:1814-1817, 1998
20. AGARWAL AK, ROGERSON FM, MUNE T, WHITE PC: Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. Genomics 29:195-199, 1995
21. CAVALLI-SFORZA LL, PIAZZA A: Human genomic diversity in Europe: A summary of recent research and prospects for the future. Eur J Hum Genet 1:3-18, 1993
22. ZAEHNER T, PLUESHKE V, FREY BM, et al: Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease. Kidney Int 58:1413-1419, 2000
23. BLUMENFELD JD, LARAGH JH: Renin system analysis: A rational method for the diagnosis and treatment of the individual patient with hypertension. Am J Hypertens 11:894-896, 1998
24. LIFTON RP, GHARAVI AC, GELLER DS: Molecular mechanisms of human hypertension. Cell 104:545-556, 2001
25. LI A, LI KX, MARUI S, et al: Apparent mineralocorticoid excess in a Brazilian kindred: Hypertension in the heterozygote state. J Hypertens 15:1397-1402, 1997
26. FISHER ND, HURWITZ S, JEUNEMAITRE X, et al: Familial aggregation of low-renin hypertension. Hypertension 39:914-918, 2002
27. WHITE PC, AGARWAL AK, LI A, et al: Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase to hypertension in black people. Clin Endocrinol 55:249-252, 2001
28. WHITE PC, AGARWAL AK, NUNEZ BS, et al: Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase. Endocr Res 26:771-780, 2000
29. MORIMOTO A, UZU T, FUJII T, et al: Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350:1734-1737, 1997